Re: The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-stage Prostate Cancer

被引：0
|
作者：
Turkeri, Levent [1 ]
Ozen, Haluk [2 ]
机构：
[1] Acibadem MA Aydinlar Univ, Dept Urol, Istanbul, Turkiye
[2] Hacettepe Univ, Dept Urol, Ankara, Turkiye
来源：
EUROPEAN UROLOGY | 2023年 / 83卷 / 03期
关键词：
D O I：
10.1016/j.eururo.2022.12.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296 / 296
页数：1
相关论文
共 50 条
  • [21] THE EFFECT OF PROSTATE VOLUME ON GRADE PROGRESSION AND TREATMENT DECISIONS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER ON ACTIVE SURVEILLANCE
    Ali, David
    Rezaee, Michael
    Jing, Yuezhou
    Fletcher, Sean
    Landis, Patricia
    Mamawala, Mufaddal
    Nimmagadda, Naren
    Pavlovich, Christian P.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E544 - E544
  • [22] Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer Reply
    不详
    JOURNAL OF UROLOGY, 2020, 204 (06): : 1221 - 1221
  • [23] Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI?
    Bhanji, Yasin
    Mamawala, Mufaddal K.
    Fletcher, Sean A.
    Landis, Patricia
    Patel, Hiten D.
    Macura, Katarzyna J.
    Pavlovich, Christian P.
    JOURNAL OF UROLOGY, 2025, 213 (01): : 20 - 26
  • [24] Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer
    Baraban, Ezra
    Erak, Eric
    Fatima, Aisha
    Akbari, Amir
    Zhao, Jianping
    Fletcher, Sean A.
    Bhanji, Yasin
    de la Calle, Claire M.
    Mamawala, Mufaddal
    Landis, Patricia
    Macura, Katarzyna J.
    Pavlovich, Christian P.
    Epstein, Jonathan I.
    JOURNAL OF UROLOGY, 2023, 210 (01): : 99 - 107
  • [25] Initial results of patients with early-stage prostate cancer on active holistic surveillance
    Katz, Aaron
    Fontes, Andrew S.
    Kosinski, Kaitlin E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [26] Is Active Surveillance the Preferred Management for Men with Early-Stage Prostate Cancer? A Decision Analysis Using the Protect Trial
    Bledsoe, T. J.
    Stahl, J. M.
    Johnson, S. B.
    Nath, S. K.
    Yu, J. B.
    Lester-Coll, N. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S206 - S207
  • [27] Re: Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center Reply
    不详
    JOURNAL OF UROLOGY, 2020, 204 (05): : 1064 - 1065
  • [28] A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression
    Wong, Lih-Ming
    Alibhai, Shabbir M. H.
    Trottier, Greg
    Timilshina, Narhari
    Van der Kwast, Theodorus
    Zlotta, Alexandre
    Lawrentschuk, Nathan
    Kulkarni, Girish
    Hamilton, Robert
    Ferrara, Sarah
    Margel, David
    Trachtenberg, John
    Jewett, Michael A.
    Toi, Ants
    Evans, Andrew
    Fleshner, Neil E.
    Finelli, Antonio
    EUROPEAN UROLOGY, 2014, 66 (03) : 406 - 413
  • [29] Active surveillance should be considered for select men with Grade Group 2 prostate cancer
    Kelly R. Pekala
    Oskar Bergengren
    James A. Eastham
    Sigrid V. Carlsson
    BMC Urology, 23
  • [30] Active surveillance should be considered for select men with Grade Group 2 prostate cancer
    Pekala, Kelly R.
    Bergengren, Oskar
    Eastham, James A.
    Carlsson, Sigrid V.
    BMC UROLOGY, 2023, 23 (01)
12345